Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live08-10

Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.5%.

Sionna Therapeutics (SION) shares fell more than 89% after the company said it will not advance SION-719 as an add-on therapy to standard of care Trikafta in cystic fibrosis patients after a phase 2a proof-of-concept failed to meet its key activity endpoint of sweat chloride reduction.

AbCellera Biologics' (ABCL) ABCL635 met the primary efficacy endpoints in the phase 2 portion of a Phase 1/2 study, significantly lowering the frequency and severity of moderate-to-severe hot flashes versus placebo, the company said. AbCellera Biologics stock was up more than 33% pre-bell.

Axsome Therapeutics (AXSM) shares were up more than 2% after the company posted a higher Q2 revenue.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment